Weight Management in Obese Cancer Patients During Curative Active Treatment

NCT ID: NCT07058207

Last Updated: 2025-07-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-22

Study Completion Date

2027-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a feasibility study intervention to fifty cancer patients with obesity and with newly diagnosed stage II-IV solid tumors undergoing curative treatment recruited at the Catalan Institute of Oncology (ICO) in L'Hospitalet, Spain.

The investigators hypothesize that weight management during cancer treatment could enhance health outcomes for this population. The feasibility of a multimodal weight loss management program will be assesses, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The single-arm intervention will consist of a multimodal weight management program, including a personalized hypocaloric and high-protein diet combined with a supervised exercise home-program and behavioural support. Hypocaloric diet will be individualized according to their energy requirements estimated and then applying a 20% caloric restriction. In order to reduce body weight and maintain muscle mass, a high-protein diet will be provided consisting of 1.5 g of protein/kg/day.

Participants will be provided with a 3-day food record (3-DFR) chart prior to their baseline visit. After a full nutritional evaluation, the dietitian will create a diet plan unique to the participant. For those participants struggling to attain their recommended intake or anticipating protein intake to be challenging, an oral whey powder supplement will be provided for the duration of the study. Additional approaches to overcoming dietary challenges will include information/resources on nutritional symptom management that can impact dietary intake and/or high-protein recipes.

The exercise program will be based on supervised aerobic and resistance exercise home-based training sessions 3 times/week. The sessions will be 60 minutes long and will include 5 minutes of flexibility, followed by 25 minutes of aerobic exercises, 25 minutes of resistance exercises, and 5 minutes of balance exercises. The physiotherapist will supervise the sessions and will provide monthly individual face-to-face counselling to assure adherence to the protocol. The investigators have designed an individualized exercise program that fits the current patient's clinical situation. Each patient will receive a fitness tracker band to monitor his/her activity.

Behavioural support will include problem-solving strategies and practical tools to facilitate participants' self-control on emotional eating or stress-driven behaviours. Targeted behaviour goals will be set. A psychologist will provide technical support and training to the dietitian and the physiotherapist to improve their skills to provide behavioural changes and motivation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Solid Neoplasm Stage II-IV Curative Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Single-arm intervention study designed to assess feasibility, accrual rate, retention, compliance and safety of a multimodal weight management program in obese cancer patients undergoing curative treatment.
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cancer patients with obesity with active curative treatment

Fifty adult cancer patients with obesity (BMI ≥30 kg/m²) newly diagnosed with stage II-IV solid tumors undergoing curative-intent treatment. Participants will receive a multimodal weight management program combining dietary intervention, physicial activity and behavioral support.

Group Type EXPERIMENTAL

Multimodal weight management program

Intervention Type BEHAVIORAL

This intervention consists of three components:

* Nutritional Counseling:

* A personalized hypocaloric and high-protein diet is prescribed, based on individual energy requirements with a 20% caloric reduction.
* The protein intake target is 1.5 g/kg/day to promote fat loss while maintaining muscle mass.
* Exercise Program

* Home-based, supervised aerobic and resistance training sessions conducted 3 times per week.
* Each 60-minute session includes: 5 minutes flexibility, 25 minutes aerobic training, 25 minutes resistance training, and 5 minutes balance exercises.
* Behavioral Support

* Patients receive training in problem-solving strategies, motivation, and emotional self-regulation to improve adherence to both dietary and exercise goals.
* Health professionals delivering the intervention are trained in behavior change techniques by a clinical psychologist.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Multimodal weight management program

This intervention consists of three components:

* Nutritional Counseling:

* A personalized hypocaloric and high-protein diet is prescribed, based on individual energy requirements with a 20% caloric reduction.
* The protein intake target is 1.5 g/kg/day to promote fat loss while maintaining muscle mass.
* Exercise Program

* Home-based, supervised aerobic and resistance training sessions conducted 3 times per week.
* Each 60-minute session includes: 5 minutes flexibility, 25 minutes aerobic training, 25 minutes resistance training, and 5 minutes balance exercises.
* Behavioral Support

* Patients receive training in problem-solving strategies, motivation, and emotional self-regulation to improve adherence to both dietary and exercise goals.
* Health professionals delivering the intervention are trained in behavior change techniques by a clinical psychologist.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult (age 18+) with pathologically confirmed malignant solid tumors, stage II-IV, elected for oncological treatment (chemo, radio, or both) with curative intend.
* Expected oncological treatment time ≥ 3 months.
* BMI ≥ 30 kg/m²
* Resident in the Barcelona area up to the completion of cancer treatment.
* ECOG Perfomance Status (PS) 0-1
* Availability of internet access.

Exclusion Criteria

* Patients with melanoma and brain tumours.
* Surgery as the only treatment.
* Tumour localizations with high risk of malnutrition (such as head and neck, upper gastrointestinal tract, or pancreatic cancer):
* Pregnancy or breastfeeding
* Another active malignancy
* Current health or medical condition that affects weight status, e.g., untreated hyper- or hypothyroidism,etc
* Pre-existing medical condition that precludes adherence to unsupervised exercise, e.g., severe orthopedic conditions, scheduled for a hip or knee replacement, bone metastases, paralysis, dementia, untreated stage 3 hypertension, or unstable angina, heart attack, congestive heart failure or conditions that dictated hospitalization or oxygen within 6-months.
* Unable to read or understand Spanish or Catalan
* Enrolled in a weight loss program
* Active suicidal ideation, anorexia, bulimia, binge eating disorder, current substance abuse or dependence (besides nicotine dependence)
* Use of pacemaker or another electrical implanted device
* History of bariatric (or LapBand) surgery, or considering or currently on a wait-list for bariatric or LapBand surgery
* Patients with any concurrent medical or psychological condition that, in the investigator's opinion, would jeopardize the safety of the patient or compliance with the protocol.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

World Cancer Research Fund International

OTHER

Sponsor Role collaborator

Institut Català d'Oncologia

OTHER

Sponsor Role collaborator

Institut d'Investigació Biomèdica de Bellvitge

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Lorena Arribas

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lorena Arribas, PhD, MsC, RD

Role: PRINCIPAL_INVESTIGATOR

Catalan Institute of Oncology (ICO-Hospitalet). Bellvitge Biomedical Research Institute (IDIBELL)

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institut Català d'Oncologia. Catalan Institute of Oncology

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Lorena Arribas

Role: CONTACT

+34932607751

Marta Puig

Role: CONTACT

+34932607751

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lorena Arribas

Role: primary

+34932607751

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PR079/25

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.